首页> 外国专利> CLASSIFICATION AND RISK-ASSIGNMENT OF CHILDHOOD ACUTE MYELOID LEUKAEMIA (AML) BY GENE EXPRESSION SIGNATURES

CLASSIFICATION AND RISK-ASSIGNMENT OF CHILDHOOD ACUTE MYELOID LEUKAEMIA (AML) BY GENE EXPRESSION SIGNATURES

机译:基因表达签名对儿童急性髓性白血病(AML)的分类和风险分配

摘要

The present invention relates to methods of genetic analysis for the classification, diagnosis and prognosis of acute myeloid leukemia (AML). The invention provides a method for producing a classification scheme for childhood acute myeloid leukaemia (AML) comprising the steps of: a) providing a plurality of reference samples, said reference samples comprising cell samples from a plurality of reference subjects suffering from childhood AML, with known class of childhood AML, and optionally known prognosis; b) providing reference profiles by establishing a gene expression profile, matched with parameters for class, and optionally prognosis for each of said reference samples individually; and c) construction of a classifier based upon the gene expression profiles of said reference samples, according to a double-loop cross- validation procedure.
机译:本发明涉及用于急性髓性白血病(AML)的分类,诊断和预后的遗传分析方法。本发明提供了一种用于产生儿童急性髓细胞性白血病(AML)的分类方案的方法,该方法包括以下步骤:a)提供多个参考样品,所述参考样品包括来自多个患有儿童AML的参考受试者的细胞样品,其中儿童AML的已知类别,以及可选的已知预后; b)通过建立与类别参数匹配的基因表达谱来提供参考谱,并且任选地分别为每个所述参考样品预后; c)根据双环交叉验证程序,基于所述参考样品的基因表达谱构建分类器。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号